CareDx获Eurobio Scientific授予北美地区体外诊断试剂永久独家分销权

美股速递
Apr 16

CareDx公司宣布,已与Eurobio Scientific达成一项重要授权协议。根据协议条款,Eurobio Scientific授予CareDx在北美地区分销其体外诊断试剂的永久性独家权利。

这项战略合作将显著扩大CareDx在移植诊断领域的产品组合,强化其在北美市场的领导地位。通过获得Eurobio Scientific创新诊断技术的独家分销权,CareDx能够为临床医生和患者提供更全面的解决方案。

独家永久权利的授予为CareDx建立了长期稳定的业务增长基础,同时也体现了Eurobio Scientific对CareDx市场开拓能力的充分信任。此次合作预计将产生显著的协同效应,进一步提升CareDx在移植诊断领域的竞争力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10